135 related articles for article (PubMed ID: 35587449)
1. Microbial Keratitis in Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Experience From a Tertiary Centre in Taiwan.
Tsai TY; Adiyabazar D; Hsiao CH; Pan LY; Chen SY; Tsai YJ; Chen CB; Chung WH; Ma DH
Cornea; 2023 Jan; 42(1):66-73. PubMed ID: 35587449
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional comparative study on chronic ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese eyes: a 15-year case series.
Chow LLW; Ng ALK; Chow SSW; Choy BNK; Shih KC; Wong IYH; Chan JCY; Lai JSM
Int Ophthalmol; 2018 Jun; 38(3):1155-1160. PubMed ID: 28547534
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Treatment of Ophthalmic Sequelae of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis at a Tertiary Eyecare Centre in Hungary.
Tóth G; Lukács A; Stachon T; Schirra F; Sándor GL; Nagy ZZ; Szentmáry N
Ophthalmol Ther; 2024 May; 13(5):1343-1356. PubMed ID: 38507192
[TBL] [Abstract][Full Text] [Related]
4. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome.
Di Pascuale MA; Espana EM; Liu DT; Kawakita T; Li W; Gao YY; Baradaran-Rafii A; Elizondo A; Raju VK; Tseng SC
Ophthalmology; 2005 May; 112(5):904-12. PubMed ID: 15878074
[TBL] [Abstract][Full Text] [Related]
5. Acute and Chronic Ophthalmic Involvement, Severity, and Sequelae in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Ganekal S; Nagarajappa A
Korean J Ophthalmol; 2021 Jun; 35(3):179-187. PubMed ID: 33596622
[TBL] [Abstract][Full Text] [Related]
6. Microbial keratitis in Stevens-Johnson syndrome: Clinical and microbiological profile.
Bagga B; Motukupally SR; Mohamed A
Ocul Surf; 2018 Oct; 16(4):454-457. PubMed ID: 29981457
[TBL] [Abstract][Full Text] [Related]
7. Microbial Keratitis in Stevens-Johnson Syndrome: A Prospective Study.
Sharma N; Venugopal R; Singhal D; Maharana PK; Sangwan S; Satpathy G
Cornea; 2019 Aug; 38(8):938-942. PubMed ID: 30998617
[TBL] [Abstract][Full Text] [Related]
8. [Factors associated with the severity of acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa].
Saka B; Dzidzinyo K; Akakpo S; Téclessou J; Nouhou Diori A; Maneh N; Mahamadou G; Gnassingbé W; Abilogun-Chokki A; Mouhari-Toure A; Boubacar YA; Kombaté K; Balo K; Tchangai-Walla K; Pitché P
Ann Dermatol Venereol; 2018 Apr; 145(4):245-249. PubMed ID: 29487020
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Effect of a Treatment Protocol for Acute Ocular Involvement in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Shanbhag SS; Rashad R; Chodosh J; Saeed HN
Am J Ophthalmol; 2019 Dec; 208():331-341. PubMed ID: 31326519
[TBL] [Abstract][Full Text] [Related]
10. Infectious Keratitis in Limbal Stem Cell Deficiency: Stevens-Johnson Syndrome Versus Chemical Burn.
Kang BS; Kim MK; Wee WR; Oh JY
Cornea; 2016 Jan; 35(1):51-5. PubMed ID: 26555593
[TBL] [Abstract][Full Text] [Related]
11. Ocular Manifestations and Outcomes in Children With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Comparison With Adult Patients.
Chen YL; Tsai TY; Pan LY; Tsai YJ; Chen SY; Hsiao CH; Yeh LK; Tan HY; Chen HC; Hung KH; Quan W; Chen CB; Chung WH; Ma DH
Am J Ophthalmol; 2023 Dec; 256():108-117. PubMed ID: 37633318
[TBL] [Abstract][Full Text] [Related]
12. Diphtheroids as Corneal Pathogens in Chronic Ocular Surface Disease in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Shanbhag SS; Shih G; Bispo PJM; Chodosh J; Jacobs DS; Saeed HN
Cornea; 2021 Jun; 40(6):774-779. PubMed ID: 33758140
[TBL] [Abstract][Full Text] [Related]
13. Multistep Grading System for Evaluation of Chronic Ocular Sequelae in Patients With Stevens-Johnson Syndrome.
Sharma N; Venugopal R; Maharana PK; Chaniyara M; Agarwal T; Pushker N; Pandey RM; Sangwan S; Sen S; Kashyap S; Sharma A; Khanna N; Vajpayee RB
Am J Ophthalmol; 2019 Jul; 203():69-77. PubMed ID: 30731084
[TBL] [Abstract][Full Text] [Related]
14. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Chi MH; Chung WH; Hui RC; Chen CB; Lu CW; Chiu TM; Ma DH; Wang CW; Yang CY;
J Dermatol; 2022 Sep; 49(9):895-902. PubMed ID: 35715971
[TBL] [Abstract][Full Text] [Related]
16. Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children.
Catt CJ; Hamilton GM; Fish J; Mireskandari K; Ali A
Am J Ophthalmol; 2016 Jun; 166():68-75. PubMed ID: 27018234
[TBL] [Abstract][Full Text] [Related]
17. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
De Rojas MV; Dart JK; Saw VP
Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of chronic ocular complications in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Van Zyl L; Carrara H; Lecuona K
Middle East Afr J Ophthalmol; 2014; 21(4):332-5. PubMed ID: 25371640
[TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications.
Ueta M
Expert Rev Clin Immunol; 2020 Mar; 16(3):285-291. PubMed ID: 32045311
[No Abstract] [Full Text] [Related]
20. Long-term Progression of Ocular Surface Disease in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Yoshikawa Y; Ueta M; Fukuoka H; Inatomi T; Yokota I; Teramukai S; Yokoi N; Kinoshita S; Tajiri K; Ikeda T; Sotozono C
Cornea; 2020 Jun; 39(6):745-753. PubMed ID: 32028281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
